Changchun High-Tech Industry Group Co Ltd
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
20 / 1328
Position in country
129 / 7387
Return on Assets, %
16.9
-2.7
Net income margin, %
30.5
2.8
EBITDA margin, %
40.1
10.8
Debt to Equity, %
8
19.2
Intangible assets and goodwill, %
9.5
3.6
Revenue CAGR 3Y, %
19.3
8.5
Total Equity change 1Y, %
18.8
0
Revenue Y, % chg
9.2
0.5
P/E
10.6
22.7
P/BV
2.1
1.5
P/S
3.2
2.3
EV/S
3
2.4
EV/EBITDA
8
7.4
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
72.4
51.3
Forward P/E
8.9
15.6
Dividend Yield, %
3.8
1.7
Forward Dividend Yield, %
0.2
0.2
Expected dividend per share
0.3
0
Payout Ratio, %
39.9
30.3
Dividend Ex Date
2024-04-18
Competitors
Ranks
-
Changchun High-Tech Industry Group Co Ltd
00%
-
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
00%
-
CSPC Pharmaceutical Group Ltd
00%
-
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
00%
-
Beijing Tongrentang Co Ltd
00%
-
Yunnan Baiyao Group Co Ltd
00%
-
Hansoh Pharmaceutical Group Company Ltd
00%
-
Zhejiang Nhu Co Ltd
00%
-
Jiangsu Hengrui Pharmaceuticals Co Ltd
00%
-
Shanghai Fosun Pharmaceutical Group Co Ltd
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
China
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals
Sub-sector
Health Care
Capitalization (millions of $)
6596.4
Ticker
000661.SZ
ISIN
CNE0000007J8
IPO date
1996-12-18
Availability on Russian exchanges
No
Reporting for
2024-03-19
Date fact. publication of reports
2023-12-31
Company Description
Changchun High & New Technology Industries (Group) Inc. is a China-based company principally engaged in bio-pharmaceutical and healthcare businesses. The Company’s main products include polyethylene glycol recombinant human growth hormone injection, recombinant human growth hormone, recombinant human follicle stimulating hormone for injection, freeze-dried live attenuated varicella vaccines and rabies vaccines for human use, among other. The Company is also involved in real estate development and property management businesses. The Company operates its business mainly in domestic market.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: